Endosomal TLRs and their accessory proteins: cell biology and biochemistry
内体 TLR 及其辅助蛋白:细胞生物学和生物化学
基本信息
- 批准号:8454409
- 负责人:
- 金额:$ 35.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-10 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsAntibodiesAntibody FormationAntigen PresentationAntigen-Presenting CellsAntigensAutoimmunityB-Cell ActivationB-LymphocytesBehaviorBiochemicalBiochemistryBiologicalBiologyCell LineCell NucleusCell physiologyCell surfaceCellsCellular biologyCherry - dietaryChimeric ProteinsClostridium perfringens theta-toxinComplementConfocal MicroscopyDifferentiation AntigensElementsEpitopesGenerationsGenetic ScreeningHaploidyHost DefenseIgG1Immune responseImmune systemImmunityImmunoglobulin Class SwitchingImmunoglobulin Switch RecombinationKnowledgeLabelLaboratory StudyLifeLigand BindingLigandsMetabolicModelingMolecularMusNucleic AcidsOvalbuminPathway interactionsPatternProcessProductionPropertyProteinsReceptor ActivationReceptor SignalingReceptors, Antigen, B-CellRefractoryResearchRoleSignal TransductionSiteSourceSpecificitySystemT cell responseT-LymphocyteTLR3 geneTLR7 geneTechniquesToll-like receptorsTransfectionTransgenesTransgenic AnimalsTransgenic MiceViralbasecell typecellular imagingcofactorcytokinedesignhuman TLR7 proteinimprovedmacrophagemicrobialmouse modelnovelpathogenphagocytosis receptorprogramsreceptorreceptor mediated endocytosisresearch studyresponsesomatic cell nuclear transfertooltraffickingvaccine efficacy
项目摘要
DESCRIPTION (provided by applicant): A detailed understanding of the trafficking behavior of the endosomal TLRs, as exemplified by that of TLR9, should aid in the design of strategies that improve delivery of antigen to processing compartments in professional antigen presenting cells, concomitant with appropriate activation of the antigen presenting cell. Consequently, this knowledge is expected to contribute to an understanding of the efficacy of vaccines currently in use, and how to improve on them. B cells represent a special target in this regard, as they not only capture antigen via a signaling receptor, the B cell receptor for antigen, which then activates the B cell, but they also possess TLRs whose engagement contributes to B cell activation per se. Other antigen presenting cells that require engagement of TLRs for full activation, production of cytokines and display of costimulatory molecules capture antigen by other means, including phagocytosis and receptor mediated endocytosis, using signaling apparatus distinct form that available to B cells. Cell-autonomous and cell type-specific factors that control endosomal TLR trafficking and function are therefore likely to be important. To address these questions, new animal models have been generated. These include a TLR9-GFP transgenic mouse, to be complemented by a TLR7-GFP mouse, and a transnuclear (TN) mouse model made by somatic cell nuclear transfer, using the nucleus of an ovalbumin-specific B cell as nucleus donor; the resulting mice possess B cells that produce ovalbumin-specific IgG1. Having established an important role for Unc93B1 in escorting functional endosomal TLRs to their site of action, much of the biochemical and cell biological details that underlie Unc93B1s function remain to be determined. The differential requirements displayed by TLR7 and TLR9 for distinct structural elements within Unc93B1 require a molecular explanation. Combined, the results of the proposed experiments, performed with altogether new mouse models, should illuminate the cell biology and function of a class of TLRs of known importance to host defense and implicated in autoimmunity. A combination of live cell imaging, biochemistry and functional readouts (cytokine production, expression of activation markers, antigen presentation) will be applied to the following aims: Aim 1: The TLR-GFP animal models will be applied to study endosomal Toll-like receptor 7 and 9 (TLR7/9) ligand binding, trafficking and proteolytic cleavage, to identify novel TLR7/9 cofactors required for trafficking, signaling and/or cleavage and to identify new players in TLR7/9 signaling. Aim 2: The TLR-GFP mice will be combined with the ovalbumin-specific TN mice to analyze the synergy between TLR and BCR signaling in B cell activation in response to a combination of BCR and TLR ligands. Aim 3: The molecular determinants of UNC93B1 required for trafficking, interaction and activation of TLRs will be examined, making use of new chemoenzymatic tools to study its topology and interacting partners.
描述(由申请人提供):以TLR9为例,对内体TLR运输行为的详细了解应有助于设计策略,以改进向专业抗原提呈细胞中的处理隔室递送抗原,并伴随着抗原提呈细胞的适当激活。因此,这些知识有望有助于理解目前正在使用的疫苗的效力,以及如何改进它们。在这方面,B细胞是一个特殊的靶标,因为它们不仅通过信号受体(B细胞抗原受体)捕获抗原,然后激活B细胞,而且它们还拥有TLRs,其参与本身有助于B细胞的激活。其他需要TLRs充分激活、产生细胞因子和展示共刺激分子的抗原提呈细胞通过其他方式捕获抗原,包括吞噬和受体介导的内吞作用,使用与B细胞不同的信号机制。因此,控制内体TLR运输和功能的细胞自主和特定细胞类型的因素可能是重要的。为了解决这些问题,产生了新的动物模型。其中包括一只TLR9-GFP转基因小鼠,并辅之以一只TLR7-GFP小鼠,以及一个通过体细胞核移植建立的跨核(TN)小鼠模型,该模型使用卵白蛋白特异性B细胞的核作为核供体;由此产生的小鼠拥有产生卵白蛋白特异性IgG1的B细胞。已经确定了Unc93B1在护送功能性内体TLRs到其作用部位的重要作用,但构成Unc93B1功能的许多生化和细胞生物学细节仍有待确定。TLR7和TLR9对Unc93B1内不同结构元素的不同要求需要分子解释。总而言之,用全新的小鼠模型进行的拟议实验的结果,应该可以阐明一类TLRs的细胞生物学和功能,这些TLRs对宿主防御具有已知的重要性,并与自身免疫有关。结合活细胞成像、生物化学和功能读数(细胞因子的产生、激活标记的表达、抗原呈递)将被应用于以下目的:1:TLR-GFP动物模型将用于研究内体Toll样受体7和9(TLR7/9)的配基结合、运输和蛋白水解性切割,以确定运输、信号和/或切割所需的新的TLR7/9辅助因子,并确定TLR7/9信号中的新成员。目的:将TLR-GFP小鼠与卵清蛋白特异性TN小鼠相结合,分析TLR和BCR信号在BCR和TLR配体结合反应中对B细胞活化的协同作用。目的3:利用新的化学酶工具研究TLRs的运输、相互作用和激活所需的UNC93B1的分子决定因素,以研究其拓扑结构和相互作用伙伴。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hidde L. Ploegh其他文献
Translating cell biology in vitro to immunity in vivo
将体外细胞生物学转化为体内免疫
- DOI:
10.1038/nature02762 - 发表时间:
2004-07-08 - 期刊:
- 影响因子:48.500
- 作者:
Marianne Boes;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Procédés de ligature et utilisations associées
结扎与应用协会程序
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
Hidde L. Ploegh;John M. Antos;Maximilian Wei;Carla P. Guimaraes - 通讯作者:
Carla P. Guimaraes
A mouse monoclonal antibody against Alexa Fluor 647.
针对 Alexa Fluor 647 的小鼠单克隆抗体。
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Irene Wuethrich;E. Guillén;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
Sec61 介导的膜蛋白从内质网转移到蛋白酶体进行降解
- DOI:
10.1038/384432a0 - 发表时间:
1996-12-05 - 期刊:
- 影响因子:48.500
- 作者:
Emmanuel J. H. J. Wiertz;Domenico Tortorella;Matthew Bogyo;Joyce Yu;Walther Mothes;Thomas R. Jones;Tom A. Rapoport;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
基于纳米抗体的双特异性抗体衔接子靶向 CTLA-4 或 PD-L1 用于癌症免疫治疗
- DOI:
10.1038/s41551-025-01447-z - 发表时间:
2025-07-16 - 期刊:
- 影响因子:26.600
- 作者:
Xin Liu;Camille Le Gall;Ryan K. Alexander;Ella Borgman;Thomas Balligand;Hidde L. Ploegh - 通讯作者:
Hidde L. Ploegh
Hidde L. Ploegh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hidde L. Ploegh', 18)}}的其他基金
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10464850 - 财政年份:2021
- 资助金额:
$ 35.75万 - 项目类别:
Non-invasive imaging of the anti-tumor immune response
抗肿瘤免疫反应的非侵入性成像
- 批准号:
10520018 - 财政年份:2020
- 资助金额:
$ 35.75万 - 项目类别:
Non-invasive imaging of the anti-tumor immune response
抗肿瘤免疫反应的非侵入性成像
- 批准号:
10318578 - 财政年份:2020
- 资助金额:
$ 35.75万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10461021 - 财政年份:2019
- 资助金额:
$ 35.75万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10208670 - 财政年份:2019
- 资助金额:
$ 35.75万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10671648 - 财政年份:2019
- 资助金额:
$ 35.75万 - 项目类别:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
通过纳米抗体的细胞内扰动对泛素结合 (E2) 酶家族施加顺序
- 批准号:
10002176 - 财政年份:2019
- 资助金额:
$ 35.75万 - 项目类别:
Non-invasive imaging of the immune response based on the use of isotopically labeled single domain antibody fragments
基于使用同位素标记的单域抗体片段的免疫反应的非侵入性成像
- 批准号:
8873207 - 财政年份:2015
- 资助金额:
$ 35.75万 - 项目类别:
Sortase-mediated installation of recognition modules on T cells for redirected ki
分选酶介导在 T 细胞上安装识别模块以实现重定向 ki
- 批准号:
8683479 - 财政年份:2014
- 资助金额:
$ 35.75万 - 项目类别:
Enzymatic modification of anti-DEC205 to manipulate its immunogenic properties
酶促修饰抗 DEC205 以操纵其免疫原性特性
- 批准号:
8386128 - 财政年份:2012
- 资助金额:
$ 35.75万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 35.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




